Mymetics Corp (MYMX)

[Phosphene]

Recently, Great efforts were made to fabricate a virosome-based vaccine platform against a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. (1st paragraph)

Conclusion:

To date, many virosome products are approved by administration authorities in different countries and commercialized. ***Not a single one by Mymetics***

Transvac 2 is a new virosomal vaccine designed against sarscov2 viruses that are in phase ?? clinical trials.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049750/#bb0285

The insiders know...
The Iranians know...
The Swiss newspaper reporter knows...

Crickets here.